Nextech Invest’s Mersana Therapeutics MRSN Stock Holding History

Nextech Invest’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-482,689	Closed	-$14M	–	18
2025 Q4	$14M	Hold	482,689	–	–	1.35%	10
2025 Q3	$3.75M	Sell	482,689 -1	-0%	-$8	0.57%	14
2025 Q2	$3.57M	Hold	482,690	–	–	0.68%	15
2025 Q1	$4.15M	Hold	482,690	–	–	0.97%	13
2024 Q4	$17.3M	Hold	482,690	–	–	2.8%	6
2024 Q3	$22.8M	Buy	482,690 +101,644	+27%	+$4.48M	3.2%	8
2024 Q2	$19.1M	Buy	381,046 +226,793	+147%	+$16.4M	3.22%	9
2024 Q1	$17.3M	Sell	154,253 -84,880	-35%	-$8.44M	2.74%	12
2023 Q4	$13.9M	Buy	+239,133	New	+$9.62M	2.58%	9

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nextech Invest's MRSN Position: Q1 2026 in Review

Nextech Invest sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 482,689 shares — an estimated $14M sold.

Nextech Invest first reported a position in MRSN in Q4 2023 and held it in 9 quarters. The position peaked at $22.8M in Q3 2024. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

Nextech Invest reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
Nextech Invest sold 482,689 Mersana Therapeutics shares in Q1 2026, an estimated $14M.
Nextech Invest first reported a position in Mersana Therapeutics in Q4 2023 and held it in 9 quarters.
Nextech Invest's Mersana Therapeutics position peaked at $22.8M in Q3 2024.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Nextech Invest's 13F filing for Q1 2026, filed 15 May 2026.